Dr. Vagrecha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
26901 76th Ave
Ste 255
New Hyde Park, NY 11040Phone+1 716-470-3460Fax+1 718-343-4642
Education & Training
Saint Peter's University HospitalResidency, Pediatrics, 2015 - 2018
Dr Vaishampayan Memorial Medical CollegeClass of 2013
Certifications & Licensure
NY State Medical License 2018 - 2025
NJ State Medical License 2016 - 2020
PA State Medical License 2015 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis Start of enrollment: 2021 Jul 13
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 45 citationsThe use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.Sakshi Bami, Anshul Vagrecha, Danielle Soberman, Mohamad Badawi, Daniel Cannone
Pediatric Blood & Cancer. 2020-11-01 - 24 citationsMultisystem Inflammatory Syndrome in Children (MIS-C) and the Prothrombotic State: Coagulation Profiles and Rotational Thromboelastometry in a MIS-C Cohort.Maha Al-Ghafry, Anshul Vagrecha, Marium Malik, Chana Levine, Eliza Uster
Journal of Thrombosis and Haemostasis. 2021-06-04 - 17 citationsHemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children.Anshul Vagrecha, Mingce Zhang, Suchitra Acharya, Shannon Lozinsky, Aaron Singer
Biology. 2022-03-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
